FUROSCIX FDA approval date

The FDA approved FUROSCIX on 7 Oct 2022.

FDA approval date
7 Oct 2022

Drug identity has not yet been verified against registry records

Also recorded as FUROSEMIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-10-07DayFUROSCIXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209988", "applicant_as_listed_by_fda": "SCPHARMACEUTICALS", "brand_names": ["FUROSCIX", "FUROSCIX READYFLOW (AUTOINJECTOR)"], "active_ingredients": ["FUROSEMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20221007", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026